In this webinar, presented by Lymphoma Canada, Dr. Neil Berinstein will provide information on clinical trials for lymphoma patients – background information, what to expect when enrolled, and more. Participation in clinical trials can have advantages for lymphoma patients: they can provide access to treatments that are otherwise not available in Canada, for example, or to already available treatments used in new ways or settings. Dr. Berinstein has led many lymphoma clinical trials; he is a professor of medicine at the University of Toronto and practising hematologist with a special interest in immunotherapy.
This webinar will be moderated by Lymphoma Canada and will include an interactive question-and-answer session. It takes place at 4:00 pm Eastern Time. Those who have registered will receive a link to the recording afterwards, even if you can’t attend. See the event page on Lymphoma Canada’s website for more information.